Global Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Acute Renal Failure (ARF) (Acute Kidney Injury) Overview
  3. Therapeutics Development
  4. Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) - Overview
  5. Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) - Comparative Analysis
  6. Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under Development by Companies
  7. Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under Investigation by Universities/Institutes
  8. Acute Renal Failure (ARF) (Acute Kidney Injury) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Acute Renal Failure (ARF) (Acute Kidney Injury) - Products under Development by Companies
  13. Acute Renal Failure (ARF) (Acute Kidney Injury) - Products under Investigation by Universities/Institutes
  14. Acute Renal Failure (ARF) (Acute Kidney Injury) - Companies Involved in Therapeutics Development
  • A1M Pharma AB
  • Adrenomed AG
  • Am-Pharma B.V.
  • Angion Biomedica Corp.
  • Atox Bio Inc.
  • Cellmid Limited
  • Complexa, Inc.
  • DiaMedica Inc.
  • Digna Biotech, S.L.
  • DURECT Corporation
  • F. Hoffmann-La Roche Ltd.
  • G1 Therapeutics, Inc.
  • Ischemix, Inc.
  • Kringle Pharma, Inc.
  • NephroGenex, Inc.
  • NeuroVive Pharmaceutical AB
  • Noorik Biopharmaceuticals AG
  • Noxxon Pharma AG
  • Nyken B.V.
  • Orion Oyj
  • ProMetic Life Sciences Inc.
  • Quark Pharmaceuticals, Inc.
  • SBI Pharmaceuticals Co., Ltd.
  • Spherium Biomed S.L.
  • STATegics, Inc.
  • Thrasos Therapeutics Inc.
  • Torrent Pharmaceuticals Limited

For more information visit http://www.researchandmarkets.com/research/pnzsk3/acute_renal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716